Consideration of Audited Financial Results Standalone and Consolidated as per Indian Accounting Standards (Ind AS) along with the Audit Report of the Company for the Quarter and Year ended 31st March 2026 Took note of the Resignation of Mr. Hemant Amrish Parikh as a Non-Executive Director of the Company Took note of the Resignation of CS Chaitra Arora from the position of the CS and compliance officer Reconstitution of Committees of the Board with effect from 07th May 2026
Vivanza Biosciences: Board Meeting Outcome for Audited Financial Results For The Quarter And Year Ended On 31St March 2026
May 7, 2026
Download PDF
Vivanza Bioscience
Informed fund ideas, better judgment. Every month. Mutual Fund Insight, every month since October 2002.
Take charge. Know more. Keep more. Mutual Fund Insight helps you do all three — every month